First Tracks Biotherapeutics (TRAX) AI Analysis

TRAX$46.56-0.54 -1.15%
BiotechnologyGrowth Stock
Compare
Market cap$1.96BEnterprise value$1.46BRevenue (TTM)$0Market position—

Score

61
Neutral
Value
34
Quality
52
Growth
98

First Tracks Biotherapeutics is a growth-led story right now — Growth 98/100 is the pillar doing the heavy lifting (overall 61/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~53% upside.

First Tracks Biotherapeutics (TRAX) AI Analysis

TRAX price $46.56 -0.54 -1.15%

Ticker
TRAX
Price
$46.56
Change
-0.54 -1.15%
Market cap
$1.96B
Dividend yield
0.00%
Beta
3.37
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
61
Value
34
Quality
52
Growth
98

Stocklytics score rationale: value 34, quality 52, growth 98.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener